Present status of the use of growth hormone in short children with bone disease (diseases of the skeleton)

Journal of Pediatric Endocrinology and Metabolism

Volumn 14, Issue 1, 2001, Pages 17-26

  Kanaka Gantenbein, C ^a  

^a AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

Author keywords

Achondroplasia; Growth hormone; Hypochondroplasia; Osteogenesis imperfecta; Skeletal dysplasia

Indexed keywords

COLLAGEN; FIBROBLAST GROWTH FACTOR 3; FIBROBLAST GROWTH FACTOR RECEPTOR; GROWTH HORMONE; HUMAN GROWTH HORMONE; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C;

ACHONDROPLASIA; ADOLESCENT; ADULTHOOD; BODY HEIGHT; BONE AGE; BONE DENSITY; BONE DEVELOPMENT; BONE DISEASE; BONE DYSPLASIA; BONE MINERAL; CARTILAGE; CHILD; CHILDHOOD DISEASE; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; DRUG EFFICACY; FEMALE; GENETIC DISORDER; HUMAN; HYPOCHONDROPLASIA; LEG LENGTHENING; MAJOR CLINICAL STUDY; MALE; OSTEOGENESIS IMPERFECTA; POSITIVE FEEDBACK; PUBERTY; REVIEW; SEX DIFFERENCE; SHORT STATURE; TREATMENT OUTCOME; TREATMENT PLANNING;

ACHONDROPLASIA; BODY HEIGHT; BONE DISEASES, DEVELOPMENTAL; CHILD; FEMALE; HUMAN GROWTH HORMONE; HUMANS; MALE; OSTEOGENESIS IMPERFECTA; PUBERTY;

EID: 0035111351     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (47)

1. International classification of chondrodysplasias
2. Skeletal dysplasias
3. Clinical-molecular correlations in the skeletal dysplasias
4. Response to growth hormone in children with chondrodysplasia
5. Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia
6. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia
7. Molecular defects in achondroplasia and the effects of growth hormone treatment
8. Growth and growth hormone therapy in children with achondroplasia: A two-year experience
9. Achondroplasia
10. Growth hormone therapy in achondroplasia
11. Human growth hormone treatment in prepubertal children with achondroplasia
12. Mutations of the FGFR3 gene in 10 cases of achondroplasia in Greek patients
13. Differential effects of insulin-like growth factor I and growth hormone on developmental stages of rat growth plate chondrocytes in vivo
14. Treatment of achondroplasia with growth hormone: Six years of experience
15. Endochondral ossification in achondroplastic dwarfism
16. Standard growth curves for achondroplasia
17. Mechanism of the stimulatory effect of growth hormone on longitudinal bone growth
18. Growth hormone therapy in achondroplasia
19. Growth hormone treatment in some types of skeletal dysplasia and in some syndromes with short stature in KIGS
20. Growth hormone treatment in achondroplasia
21. Short-term recombinant human growth hormone treatment increases growth rate in achondroplasia
22. Effect of growth hormone therapy in children with achondroplasia: Growth pattern, hypothalamic-pituitary function and genotype
23. Wider indications for treatment with biosynthetic human growth hormone in children
24. Progress report: Growth hormone in skeletal dysplasias
25. Two years results on growth hormone treatment in prepubertal children with achondroplasia and hypochondroplasia: A dose study
26. Growth of the foramen magnum in achondroplasia
27. Distraction osteogenesis for lengthening of the tibia in patients who have limb-length discrepancy of short stature
28. Nerve conduction changes during lower limb lengthening. Somatosensory evoked potentials (SEPs) and F wave results
29. Growth hormone therapy in hypochondroplasia
30. Hypochondroplasia
31. Growth and growth hormone therapy in hypochondroplasia
32. Skeletal changes following growth hormone treatment in a child with combined hypopituitarism and a skeletal dysplasia
33. Osteochondrodyslasias with mild clinical manifestations: A guide for endocrinologists and others
34. Growth of children with hypochondroplasia treated with growth hormone for up to three years
35. Growth therapy and leukemia
36. Growth and growth hormone status following treatment for childhood leukemia
37. Recent progress in diagnosis and treatment of osteogenesis imperfecta
38. Growth hormone treatment in osteogenesis imperfecta with quantitative defect of type I collagen synthesis
39. Anthropometry of patients with osteogenesis imperfecta
40. Orthopaedic aspects of skeletal dysplasia in children
41. Evaluation of growth hormone axis and responsiveness to growth stimulation of short children with osteogenesis imperfecta
42. The growth hormone and somatomedin axis in short children with osteogenesis imperfecta
43. Just taller or more bone? The impact of growth hormone on osteogenesis imperfecta and idiopathic juvenile osteoporosis
44. A case of osteogenesis imperfecta type IA who accompanied increased frequency of bone fractures by GH therapy
45. Osteogenesis imperfecta: Are fractures and growth hormone treatment linked?
46. Turner syndrome and osteoporosis: Mechanisms and prognosis
47. Impact of hormonal replacement therapy on bone mineral density in women with Turner syndrome